How NGS-Based MRD Is Reshaping Hematological Malignancy Management
NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Read MorePosted by Chris Wolski | Jun 27, 2025 | Sequencing Systems |
NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Read MorePosted by Chris Wolski | Jun 26, 2025 | Molecular Diagnostics |
A study shows that saliva contains genetic markers linked to systemic diseases for a non-invasive alternative to blood-based diagnostics.
Read MorePosted by Chris Wolski | Jun 26, 2025 | Fertility Testing |
Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.
Read MorePosted by Chris Wolski | Jun 26, 2025 | Histology |
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Read MorePosted by Chris Wolski | Jun 23, 2025 | Molecular Diagnostics |
Precision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.
Read More